Tilray (NASDAQ:TLRY) Shares Gap Down to $2.15

Tilray Inc (NASDAQ:TLRY) gapped down before the market opened on Tuesday . The stock had previously closed at $2.15, but opened at $2.09. Tilray shares last traded at $2.24, with a volume of 8,657,552 shares changing hands.

Tilray Price Performance

The business’s 50-day moving average is $1.87 and its 200-day moving average is $2.00. The company has a current ratio of 1.63, a quick ratio of 0.99 and a debt-to-equity ratio of 0.11.

Insider Activity at Tilray

In other Tilray news, CEO Irwin D. Simon bought 53,700 shares of the firm’s stock in a transaction that occurred on Friday, January 12th. The stock was bought at an average cost of $1.88 per share, for a total transaction of $100,956.00. Following the completion of the transaction, the chief executive officer now directly owns 2,033,058 shares of the company’s stock, valued at approximately $3,822,149.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Tilray news, CFO Carl A. Merton bought 20,000 shares of the firm’s stock in a transaction that occurred on Friday, January 12th. The stock was bought at an average cost of $1.87 per share, for a total transaction of $37,400.00. Following the completion of the transaction, the chief financial officer now directly owns 20,000 shares of the company’s stock, valued at approximately $37,400. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Irwin D. Simon acquired 53,700 shares of the business’s stock in a transaction on Friday, January 12th. The stock was purchased at an average cost of $1.88 per share, with a total value of $100,956.00. Following the acquisition, the chief executive officer now directly owns 2,033,058 shares of the company’s stock, valued at approximately $3,822,149.04. The disclosure for this purchase can be found here. Insiders acquired 96,300 shares of company stock worth $183,210 over the last three months. Company insiders own 0.68% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in TLRY. Clear Street Markets LLC purchased a new position in Tilray in the third quarter valued at $25,000. Macquarie Group Ltd. increased its holdings in Tilray by 188.8% in the second quarter. Macquarie Group Ltd. now owns 8,540 shares of the company’s stock valued at $27,000 after buying an additional 5,583 shares in the last quarter. Oppenheimer & Co. Inc. purchased a new position in Tilray in the fourth quarter valued at $27,000. Lake Street Financial LLC purchased a new position in Tilray in the third quarter valued at $28,000. Finally, Gainplan LLC purchased a new position in Tilray in the fourth quarter valued at $28,000. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.